Cited by 286Metal-Organic Frameworks: Synthesis and ApplicationsNanoparticle-Based Drug DeliveryMesoporous Materials and Catalysis

Positioning metal-organic framework nanoparticles within the context of drug delivery – A comparison with mesoporous silica nanoparticles and dendrimers

Wuttke, Stefan, Lismont, Marjorie, Escudero, Alberto, Rungtaweevoranit, Bunyarat, Parak, Wolfgang J.·2017·Biomaterials

Abstract

Nanotechnology enables the creation of delivery vehicles able to overcome physiologically imposed barriers, allowing new approaches for reducing the unwanted side effects of systemic delivery of drug, increasing targeting efficiency and so improving therapy efficacy. Owing to the considerable advances in material sciences and pharmaceutics, a broad range of different inorganic or organic drug nanocarriers have been developed. Furthermore, researchers have shown that the combination of inorganic and organic chemistries in one single material, named metal-organic framework (MOF), offers structural designability at the molecular level together with tunable porosity and chemical functionalisability. While the MOF size can be controlled at the nanometer scale, these features are of paramount interest in the development of the next generation of drug delivery systems. After a short state-of-the-art about MOF technology and within the drug delivery context, this paper discusses the benefits of using MOF nanoparticles compared to dendrimers and mesoporous silica nanoparticles in order to understand the challenges that must still be overcome.

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2017.01.025

Cites

196 of 196 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The limitations of physiological instability and cytotoxicity of MOFs from toxic metal ions have limited their drug delivery applications.

    “However, the limitations of physiological instability and the cytotoxicity of MOFs from toxic metal ions have limited their drug delivery applications.124”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [124]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wuttke, S., Lismont, M., Escudero, A., Rungtaweevoranit, B., & Parak, W. J.
Affiliations
  • Center for NanoScience (DE)
  • University of Liège (BE)
  • Philipps University of Marburg (DE)
  • Kavli Energy NanoScience Institute (US)
Corresponding author
  • Wuttke, Stefan
  • Parak, Wolfgang J.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2017-04
Volume
123
Pages
172-183
ISSN
0142-9612 (ISSN-L)
OpenAlex
W2580236852
Cited by
286
References
196
Citations by year
2026: 13 · 2025: 30 · 2024: 15 · 2023: 24 · 2022: 22 · 2021: 31 · 2020: 32 · 2019: 50 · 2018: 54 · 2017: 15
FWCI
15.79
Type
journal article
Language
en
Open access
closed
Locations
  • Biomaterials (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • European Commission
  • Deutsche Forschungsgemeinschaft (WU 622/4-1)
  • University of Liège, Belgium (CRA2015)
Topics
  • Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Organic Frameworks: Synthesis and Applications
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Materials Science › Materials Chemistry › Mesoporous Materials and Catalysis
Keywords
metal-organic frameworks, drug delivery, mesoporous silica nanoparticles, dendrimers, drug nanocarriers, nanoparticle drug delivery, tunable porosity, chemical functionalization, targeted drug delivery
MeSH terms
Metal-Organic Frameworks, Diffusion, Particle Size, Silicon Dioxide, Porosity, Dendrimers, Nanocapsules, Nanopores, Absorption, Physicochemical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review